{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T15:57:09Z","timestamp":1775836629097,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82303129"],"award-info":[{"award-number":["82303129"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82073282"],"award-info":[{"award-number":["82073282"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["3332022037"],"award-info":[{"award-number":["3332022037"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2021-I2M-1-020"],"award-info":[{"award-number":["2021-I2M-1-020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-024-01726-7","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T16:02:22Z","timestamp":1726070542000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Genome-wide characterization of dynamic DNA 5-hydroxymethylcytosine and TET2-related DNA demethylation during breast tumorigenesis"],"prefix":"10.1186","volume":"16","author":[{"given":"Shuang-Ling","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changcai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinglin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Min","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yamei","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"issue":"7","key":"1726_CR1","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1016\/S1470-2045(13)70567-9","volume":"15","author":"L Fan","year":"2014","unstructured":"Fan L, Strasser-Weippl K, Li JJ, St Louis J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM, Goss PE. Breast cancer in China. Lancet Oncol. 2014;15(7):e279-289.","journal-title":"Lancet Oncol"},{"issue":"2","key":"1726_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1726_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJM198501173120303","volume":"312","author":"WD Dupont","year":"1985","unstructured":"Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312(3):146\u201351.","journal-title":"N Engl J Med"},{"issue":"2","key":"1726_CR4","first-page":"231","volume":"55","author":"SR Wellings","year":"1975","unstructured":"Wellings SR, Jensen HM, Marcum RG. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst. 1975;55(2):231\u201373.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"1726_CR5","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/jnci\/50.5.1111","volume":"50","author":"SR Wellings","year":"1973","unstructured":"Wellings SR, Jensen HM. On the origin and progression of ductal carcinoma in the human breast. J Natl Cancer Inst. 1973;50(5):1111\u20138.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"1726_CR6","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/BF02966399","volume":"7","author":"T Oyama","year":"2000","unstructured":"Oyama T, Iijima K, Takei H, Horiguchi J, Iino Y, Nakajima T, Koerner F. Atypical cystic lobule of the breast: an early stage of low-grade ductal carcinoma in-situ. Breast Cancer. 2000;7(4):326\u201331.","journal-title":"Breast Cancer"},{"issue":"11","key":"1726_CR7","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1002\/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A","volume":"55","author":"DL Page","year":"1985","unstructured":"Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1985;55(11):2698\u2013708.","journal-title":"Cancer"},{"issue":"3","key":"1726_CR8","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/path.5262","volume":"248","author":"T Kader","year":"2019","unstructured":"Kader T, Hill P, Zethoven M, Goode DL, Elder K, Thio N, Doyle M, Semple T, Sufyan W, Byrne DJ, et al. Atypical ductal hyperplasia is a multipotent precursor of breast carcinoma. J Pathol. 2019;248(3):326\u201338.","journal-title":"J Pathol"},{"issue":"11","key":"1726_CR9","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.6004\/jnccn.2018.7099","volume":"16","author":"PS Thomas","year":"2018","unstructured":"Thomas PS. Diagnosis and management of high-risk breast lesions. J Natl Compr Canc Netw. 2018;16(11):1391\u20136.","journal-title":"J Natl Compr Canc Netw"},{"issue":"6491","key":"1726_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1126\/science.aaz2078","volume":"368","author":"N Pashayan","year":"2020","unstructured":"Pashayan N, Pharoah PDP. The challenge of early detection in cancer. Science. 2020;368(6491):589\u201390.","journal-title":"Science"},{"issue":"10","key":"1726_CR11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/gb-2012-13-10-173","volume":"13","author":"CX Song","year":"2012","unstructured":"Song CX, He C. Balance of DNA methylation and demethylation in cancer development. Genome Biol. 2012;13(10):173.","journal-title":"Genome Biol"},{"issue":"6","key":"1726_CR12","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1042\/EBC20190037","volume":"63","author":"K Skvortsova","year":"2019","unstructured":"Skvortsova K, Stirzaker C, Taberlay P. The DNA methylation landscape in cancer. Essays Biochem. 2019;63(6):797\u2013811.","journal-title":"Essays Biochem"},{"issue":"6","key":"1726_CR13","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.cell.2012.07.033","volume":"150","author":"CG Lian","year":"2012","unstructured":"Lian CG, Xu Y, Ceol C, Wu F, Larson A, Dresser K, Xu W, Tan L, Hu Y, Zhan Q, et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell. 2012;150(6):1135\u201346.","journal-title":"Cell"},{"issue":"1","key":"1726_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cr.2015.150","volume":"26","author":"K Chen","year":"2016","unstructured":"Chen K, Zhang J, Guo Z, Ma Q, Xu Z, Zhou Y, Xu Z, Li Z, Liu Y, Ye X, et al. Loss of 5-hydroxymethylcytosine is linked to gene body hypermethylation in kidney cancer. Cell Res. 2016;26(1):103\u201318.","journal-title":"Cell Res"},{"issue":"12","key":"1726_CR15","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1136\/gutjnl-2019-318882","volume":"68","author":"J Cai","year":"2019","unstructured":"Cai J, Chen L, Zhang Z, Zhang X, Lu X, Liu W, Shi G, Ge Y, Gao P, Yang Y, et al. Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma. Gut. 2019;68(12):2195\u2013205.","journal-title":"Gut"},{"issue":"1","key":"1726_CR16","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/hep.30146","volume":"69","author":"J Liu","year":"2019","unstructured":"Liu J, Jiang J, Mo J, Liu D, Cao D, Wang H, He Y, Wang H. Global DNA 5-hydroxymethylcytosine and 5-formylcytosine contents are decreased in the early stage of hepatocellular carcinoma. Hepatology. 2019;69(1):196\u2013208.","journal-title":"Hepatology"},{"issue":"12","key":"1726_CR17","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1089\/dna.2019.4965","volume":"38","author":"H Liu","year":"2019","unstructured":"Liu H, Xu T, Cheng Y, Jin MH, Chang MY, Shu Q, Allen EG, Jin P, Wang X. Altered 5-hydroxymethylcytosine landscape in primary gastric adenocarcinoma. DNA Cell Biol. 2019;38(12):1460\u20139.","journal-title":"DNA Cell Biol"},{"issue":"1","key":"1726_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","volume":"150","author":"MA Dawson","year":"2012","unstructured":"Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell. 2012;150(1):12\u201327.","journal-title":"Cell"},{"issue":"1","key":"1726_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2217\/epi-2016-0122","volume":"9","author":"JP Thomson","year":"2017","unstructured":"Thomson JP, Meehan RR. The application of genome-wide 5-hydroxymethylcytosine studies in cancer research. Epigenomics. 2017;9(1):77\u201391.","journal-title":"Epigenomics"},{"issue":"1","key":"1726_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40880-019-0356-x","volume":"39","author":"C Zeng","year":"2019","unstructured":"Zeng C, Stroup EK, Zhang Z, Chiu BC, Zhang W. Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy. Cancer Commun. 2019;39(1):12.","journal-title":"Cancer Commun"},{"key":"1726_CR21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13148-016-0282-6","volume":"8","author":"Q Tang","year":"2016","unstructured":"Tang Q, Cheng J, Cao X, Surowy H, Burwinkel B. Blood-based DNA methylation as biomarker for breast cancer: a systematic review. Clin Epigenet. 2016;8:115.","journal-title":"Clin Epigenet"},{"issue":"12","key":"1726_CR22","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.2217\/14622416.9.12.1879","volume":"9","author":"PK Lo","year":"2008","unstructured":"Lo PK, Sukumar S. Epigenomics and breast cancer. Pharmacogenomics. 2008;9(12):1879\u2013902.","journal-title":"Pharmacogenomics"},{"issue":"4","key":"1726_CR23","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1080\/15592294.2019.1695332","volume":"15","author":"OM Wilkins","year":"2020","unstructured":"Wilkins OM, Johnson KC, Houseman EA, King JE, Marsit CJ, Christensen BC. Genome-wide characterization of cytosine-specific 5-hydroxymethylation in normal breast tissue. Epigenetics. 2020;15(4):398\u2013418.","journal-title":"Epigenetics"},{"issue":"19","key":"1726_CR24","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.3390\/cells11192939","volume":"11","author":"D Ramasamy","year":"2022","unstructured":"Ramasamy D, Rao A, Balaiah M, Vittal Rangan A, Sundersingh S, Veluswami S, Thangarajan R, Mani S. Locus-specific enrichment analysis of 5-hydroxymethylcytosine reveals novel genes associated with breast carcinogenesis. Cells. 2022;11(19):2939.","journal-title":"Cells"},{"issue":"1","key":"1726_CR25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s10549-015-3525-x","volume":"153","author":"KW Tsai","year":"2015","unstructured":"Tsai KW, Li GC, Chen CH, Yeh MH, Huang JS, Tseng HH, Fu TY, Liou HH, Pan HW, Huang SF, et al. Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER\/PR-negative subtype. Breast Cancer Res Treat. 2015;153(1):219\u201334.","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"1726_CR26","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/onc.2012.67","volume":"32","author":"H Yang","year":"2013","unstructured":"Yang H, Liu Y, Bai F, Zhang JY, Ma SH, Liu J, Xu ZD, Zhu HG, Ling ZQ, Ye D, et al. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene. 2013;32(5):663\u20139.","journal-title":"Oncogene"},{"issue":"78","key":"1726_CR27","doi-asserted-by":"publisher","first-page":"14671","DOI":"10.1039\/C5CC05921F","volume":"51","author":"Z Yang","year":"2015","unstructured":"Yang Z, Jiang W, Liu F, Zhou Y, Yin H, Ai S. A novel electrochemical immunosensor for the quantitative detection of 5-hydroxymethylcytosine in genomic DNA of breast cancer tissue. Chem Commun. 2015;51(78):14671\u20133.","journal-title":"Chem Commun"},{"issue":"5","key":"1726_CR28","doi-asserted-by":"publisher","first-page":"e23162","DOI":"10.1002\/jcla.23162","volume":"34","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Jin Y, Zhang W, Chu C, Zhang K, Gao X, Zhou J, Zou L, Tang F, Wang H, et al. Values of 5mC, 5hmC, and TET2 for identifying the presence and progression of breast precancerous lesion. J Clin Lab Anal. 2019;34(5):e23162.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"1726_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.gpb.2019.05.005","volume":"19","author":"SL Wu","year":"2021","unstructured":"Wu SL, Zhang X, Chang M, Huang C, Qian J, Li Q, Yuan F, Sun L, Yu X, Cui X, et al. Genome-wide 5-hydroxymethylcytosine profiling analysis identifies MAP7D1 as a novel regulator of lymph node metastasis in breast cancer. Genom Proteomics Bioinform. 2021;19(1):64\u201379.","journal-title":"Genom Proteomics Bioinform"},{"issue":"1","key":"1726_CR30","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3390\/ijms25010272","volume":"25","author":"EG Salmeron-Barcenas","year":"2023","unstructured":"Salmeron-Barcenas EG, Zacapala-Gomez AE, Torres-Rojas FI, Antonio-Vejar V, Avila-Lopez PA, Banos-Hernandez CJ, Nunez-Martinez HN, Dircio-Maldonado R, Martinez-Carrillo DN, Ortiz-Ortiz J, et al. TET enzymes and 5hmC levels in carcinogenesis and progression of breast cancer: potential therapeutic targets. Int J Mol Sci. 2023;25(1):272.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1726_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00428-010-1013-6","volume":"458","author":"SY Park","year":"2011","unstructured":"Park SY, Kwon HJ, Lee HE, Ryu HS, Kim SW, Kim JH, Kim IA, Jung N, Cho NY, Kang GH. Promoter CpG island hypermethylation during breast cancer progression. Virchows Arch. 2011;458(1):73\u201384.","journal-title":"Virchows Arch"},{"issue":"10","key":"1726_CR32","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1158\/1055-9965.EPI-08-0821","volume":"18","author":"MO Hoque","year":"2009","unstructured":"Hoque MO, Prencipe M, Poeta ML, Barbano R, Valori VM, Copetti M, Gallo AP, Brait M, Maiello E, Apicella A, et al. Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression. Cancer Epidemiol Biomark Prev. 2009;18(10):2694\u2013700.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"1","key":"1726_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10549-017-4488-x","volume":"167","author":"DN Danforth","year":"2018","unstructured":"Danforth DN. Molecular profile of atypical hyperplasia of the breast. Breast Cancer Res Treat. 2018;167(1):9\u201329.","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"1726_CR34","first-page":"435","volume":"15","author":"T Fleischer","year":"2014","unstructured":"Fleischer T, Frigessi A, Johnson KC, Edvardsen H, Touleimat N, Klajic J, Riis ML, Haakensen VD, Warnberg F, Naume B, et al. Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis. Genome Biol. 2014;15(8):435.","journal-title":"Genome Biol"},{"issue":"5","key":"1726_CR35","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.3892\/ijo.2014.2625","volume":"45","author":"C Minning","year":"2014","unstructured":"Minning C, Mokhtar NM, Abdullah N, Muhammad R, Emran NA, Ali SA, Harun R, Jamal R. Exploring breast carcinogenesis through integrative genomics and epigenomics analyses. Int J Oncol. 2014;45(5):1959\u201368.","journal-title":"Int J Oncol"},{"key":"1726_CR36","doi-asserted-by":"publisher","first-page":"10478","DOI":"10.1038\/ncomms10478","volume":"7","author":"AE Teschendorff","year":"2016","unstructured":"Teschendorff AE, Gao Y, Jones A, Ruebner M, Beckmann MW, Wachter DL, Fasching PA, Widschwendter M. DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer. Nat Commun. 2016;7:10478.","journal-title":"Nat Commun"},{"issue":"10","key":"1726_CR37","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1080\/15592294.2020.1747748","volume":"15","author":"ME Muse","year":"2020","unstructured":"Muse ME, Titus AJ, Salas LA, Wilkins OM, Mullen C, Gregory KJ, Schneider SS, Crisi GM, Jawale RM, Otis CN, et al. Enrichment of CpG island shore region hypermethylation in epigenetic breast field cancerization. Epigenetics. 2020;15(10):1093\u2013106.","journal-title":"Epigenetics"},{"issue":"20","key":"1726_CR38","doi-asserted-by":"publisher","first-page":"7041","DOI":"10.3390\/molecules27207041","volume":"27","author":"Y Yu","year":"2022","unstructured":"Yu Y, Pan HY, Zheng X, Yuan F, Zhou YL, Zhang XX. Ultrasensitive simultaneous detection of multiple rare modified nucleosides as promising biomarkers in low-put breast cancer DNA samples for clinical multi-dimensional diagnosis. Molecules. 2022;27(20):7041.","journal-title":"Molecules"},{"issue":"W1","key":"1726_CR39","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, Imamichi T, Chang W. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50(W1):W216\u201321.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1726_CR40","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13059-018-1435-z","volume":"19","author":"C Ma","year":"2018","unstructured":"Ma C, Chang M, Lv H, Zhang ZW, Zhang W, He X, Wu G, Zhao S, Zhang Y, Wang D, et al. RNA m(6)A methylation participates in regulation of postnatal development of the mouse cerebellum. Genome Biol. 2018;19(1):68.","journal-title":"Genome Biol"},{"issue":"16","key":"1726_CR41","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R, Subgroup GPDP. The sequence alignment\/map format and SAMtools. Bioinformatics. 2009;25(16):2078\u20139.","journal-title":"Bioinformatics"},{"issue":"5","key":"1726_CR42","doi-asserted-by":"publisher","first-page":"R71","DOI":"10.1186\/gb-2014-15-5-r71","volume":"15","author":"AL Brunner","year":"2014","unstructured":"Brunner AL, Li J, Guo X, Sweeney RT, Varma S, Zhu SX, Li R, Tibshirani R, West RB. A shared transcriptional program in early breast neoplasias despite genetic and clinical distinctions. Genome Biol. 2014;15(5):R71.","journal-title":"Genome Biol"},{"issue":"7381","key":"1726_CR43","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature10730","volume":"481","author":"CS Ross-Innes","year":"2012","unstructured":"Ross-Innes CS, Stark R, Teschendorff AE, Holmes KA, Ali HR, Dunning MJ, Brown GD, Gojis O, Ellis IO, Green AR, et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature. 2012;481(7381):389\u201393.","journal-title":"Nature"},{"issue":"7","key":"1726_CR44","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"1726_CR45","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/bioinformatics\/btv145","volume":"31","author":"G Yu","year":"2015","unstructured":"Yu G, Wang L-G, He Q-Y. ChIPseeker: an R\/bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics. 2015;31(14):2382\u20133.","journal-title":"Bioinformatics"},{"issue":"8","key":"1726_CR46","doi-asserted-by":"publisher","first-page":"108776","DOI":"10.1016\/j.celrep.2021.108776","volume":"34","author":"R Broome","year":"2021","unstructured":"Broome R, Chernukhin I, Jamieson S, Kishore K, Papachristou EK, Mao SQ, Tejedo CG, Mahtey A, Theodorou V, Groen AJ, et al. TET2 is a component of the estrogen receptor complex and controls 5mC to 5hmC conversion at estrogen receptor cis-regulatory regions. Cell Rep. 2021;34(8):108776.","journal-title":"Cell Rep"},{"issue":"D1","key":"1726_CR47","doi-asserted-by":"publisher","first-page":"D882","DOI":"10.1093\/nar\/gkz1062","volume":"48","author":"Y Luo","year":"2019","unstructured":"Luo Y, Hitz BC, Gabdank I, Hilton JA, Kagda MS, Lam B, Myers Z, Sud P, Jou J, Lin K, et al. New developments on the Encyclopedia of DNA Elements (ENCODE) data portal. Nucleic Acids Res. 2019;48(D1):D882\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"1726_CR48","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 2010;38(4):576\u201389.","journal-title":"Mol Cell"},{"issue":"W1","key":"1726_CR49","doi-asserted-by":"publisher","first-page":"W160","DOI":"10.1093\/nar\/gkw257","volume":"44","author":"F Ram\u00edrez","year":"2016","unstructured":"Ram\u00edrez F, Ryan DP, Gr\u00fcning B, Bhardwaj V, Kilpert F, Richter AS, Heyne S, D\u00fcndar F, Manke T. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 2016;44(W1):W160\u20135.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"1726_CR50","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/cr.2017.106","volume":"27","author":"C-X Song","year":"2017","unstructured":"Song C-X, Yin S, Ma L, Wheeler A, Chen Y, Zhang Y, Liu B, Xiong J, Zhang W, Hu J, et al. 5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages. Cell Res. 2017;27(10):1231\u201342.","journal-title":"Cell Res"},{"issue":"8","key":"1726_CR51","doi-asserted-by":"publisher","first-page":"e1003118","DOI":"10.1371\/journal.pcbi.1003118","volume":"9","author":"M Lawrence","year":"2013","unstructured":"Lawrence M, Huber W, Pag\u00e8s H, Aboyoun P, Carlson M, Gentleman R, Morgan MT, Carey VJ. Software for computing and annotating genomic ranges. PLoS Comput Biol. 2013;9(8):e1003118.","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"1726_CR52","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13058-020-1250-9","volume":"22","author":"TC de Ruijter","year":"2020","unstructured":"de Ruijter TC, van der Heide F, Smits KM, Aarts MJ, van Engeland M, Heijnen VCG. Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review. Breast Cancer Res. 2020;22(1):13.","journal-title":"Breast Cancer Res"},{"issue":"D1","key":"1726_CR53","doi-asserted-by":"publisher","first-page":"D882","DOI":"10.1093\/nar\/gkz1062","volume":"48","author":"Y Luo","year":"2020","unstructured":"Luo Y, Hitz BC, Gabdank I, Hilton JA, Kagda MS, Lam B, Myers Z, Sud P, Jou J, Lin K, et al. New developments on the encyclopedia of DNA elements (ENCODE) data portal. Nucleic Acids Res. 2020;48(D1):D882\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1726_CR54","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41571-020-00457-x","volume":"18","author":"M Ignatiadis","year":"2021","unstructured":"Ignatiadis M, Sledge GW, Jeffrey SS. Liquid biopsy enters the clinic\u2014implementation issues and future challenges. Nat Rev Clin Oncol. 2021;18(5):297\u2013312.","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"1726_CR55","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/cr.2017.121","volume":"27","author":"W Li","year":"2017","unstructured":"Li W, Zhang X, Lu X, You L, Song Y, Luo Z, Zhang J, Nie J, Zheng W, Xu D, et al. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers. Cell Res. 2017;27(10):1243\u201357.","journal-title":"Cell Res"},{"issue":"1","key":"1726_CR56","doi-asserted-by":"publisher","first-page":"5270","DOI":"10.1038\/s41467-020-18965-w","volume":"11","author":"GD Guler","year":"2020","unstructured":"Guler GD, Ning Y, Ku CJ, Phillips T, McCarthy E, Ellison CK, Bergamaschi A, Collin F, Lloyd P, Scott A, et al. Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA. Nat Commun. 2020;11(1):5270.","journal-title":"Nat Commun"},{"issue":"1","key":"1726_CR57","doi-asserted-by":"publisher","first-page":"R10","DOI":"10.1186\/bcr2817","volume":"13","author":"Y Li","year":"2011","unstructured":"Li Y, Li Y, Wedren S, Li G, Charn TH, Desai KV, Bonnard C, Czene K, Humphreys K, Darabi H, et al. Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer. Breast Cancer Res. 2011;13(1):R10.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"1726_CR58","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13058-018-0963-5","volume":"20","author":"MB Padua","year":"2018","unstructured":"Padua MB, Bhat-Nakshatri P, Anjanappa M, Prasad MS, Hao Y, Rao X, Liu S, Wan J, Liu Y, McElyea K, et al. Dependence receptor UNC5A restricts luminal to basal breast cancer plasticity and metastasis. Breast Cancer Res. 2018;20(1):35.","journal-title":"Breast Cancer Res"},{"issue":"10","key":"1726_CR59","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1172\/JCI137552","volume":"130","author":"EC de Heer","year":"2020","unstructured":"de Heer EC, Jalving M, Harris AL. HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer. J Clin Invest. 2020;130(10):5074\u201387.","journal-title":"J Clin Invest"},{"issue":"12","key":"1726_CR60","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.bbagrm.2014.02.007","volume":"1839","author":"NR Rose","year":"2014","unstructured":"Rose NR, Klose RJ. Understanding the relationship between DNA methylation and histone lysine methylation. Biochim Biophys Acta. 2014;1839(12):1362\u201372.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1726_CR61","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41467-021-20979-x","volume":"12","author":"E Agirre","year":"2021","unstructured":"Agirre E, Oldfield AJ, Bellora N, Segelle A, Luco RF. Splicing-associated chromatin signatures: a combinatorial and position-dependent role for histone marks in splicing definition. Nat Commun. 2021;12(1):682.","journal-title":"Nat Commun"},{"issue":"11","key":"1726_CR62","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1101\/gr.222794.117","volume":"27","author":"S Bhattacharyya","year":"2017","unstructured":"Bhattacharyya S, Pradhan K, Campbell N, Mazdo J, Vasantkumar A, Maqbool S, Bhagat TD, Gupta S, Suzuki M, Yu Y, et al. Altered hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways. Genome Res. 2017;27(11):1830\u201342.","journal-title":"Genome Res"},{"issue":"1","key":"1726_CR63","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1038\/s41467-021-24425-w","volume":"12","author":"B He","year":"2021","unstructured":"He B, Zhang C, Zhang X, Fan Y, Zeng H, Liu J, Meng H, Bai D, Peng J, Zhang Q, et al. Tissue-specific 5-hydroxymethylcytosine landscape of the human genome. Nat Commun. 2021;12(1):4249.","journal-title":"Nat Commun"},{"issue":"7","key":"1726_CR64","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41588-020-0628-z","volume":"52","author":"Z Hu","year":"2020","unstructured":"Hu Z, Li Z, Ma Z, Curtis C. Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases. Nat Genet. 2020;52(7):701\u20138.","journal-title":"Nat Genet"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-024-01726-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-024-01726-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-024-01726-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T17:03:30Z","timestamp":1726074210000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-024-01726-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1726"],"URL":"https:\/\/doi.org\/10.1186\/s13148-024-01726-7","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,11]]},"assertion":[{"value":"4 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the human tissue samples were obtained under a protocol (AF-SOP-07-1.1-0.1) approved by the Medical Scientific Research Ethics Committee of the First Affiliated Hospital of China Medical University. All subjects provided written informed consent according to the Institutional Guidelines. This study is compliant with all relevant ethical regulations regarding research involving human resources.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have given consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"125"}}